Official sponsor for European Musculo-Skeletal Oncology Society (EMSOS) Annual Meeting at La Baule (France) from May 25th to 27th, AtlAntA holding will be presenting a conference on its Research and Development on bone cancer: “HBP-bound doxorubicin: the promising new therapy for bone cancer”. Contact us to plan a meeting and discover our Group and our capabilities for R&D and preclinical evaluation services of drug candidates, in bone and joint diseases and biomaterials.
http://www.emsos2016.com